Neogen Sets Growth, R&D and Margin Targets at 2026 Investor Day
Neogen Corporation hosted its 2026 Investor Day in New York City, outlining a long-term strategy centered on category leadership, innovation, and margin expansion. The company plans to increase R&D investment by roughly 50% in FY2027, targeting 5% of revenue by FY2031 to enhance customer solutions. Financially, Neogen targets high-single-digit to low-double-digit total revenue growth, high-50% adjusted gross margins, and a 30% adjusted EBITDA margin by FY2031. This framework is underpinned by disciplined free cash flow generation and a net leverage target of under 2.5x.
Neogen Corporation (NASDAQ: NEOG) hosted its 2026 Investor Day, titled “Shaping the Future of Food Safety,” in New York City. The company’s senior leadership team outlined a long-term strategy focused on sustained profitable growth, category leadership, innovation and margin expansion.
As part of the strategy, Neogen plans to increase research and development investment by approximately 50% in FY2027. The company is also targeting R&D investment equal to approximately 5% of revenue by FY2031, with the aim of expanding its solutions to meet customer needs.
Neogen’s financial framework targets high-single-digit to low-double-digit total revenue growth by FY2031. The company also aims to achieve an adjusted gross margin in the high-50% range and a 30% adjusted EBITDA margin by that fiscal year.
The framework is supported by Neogen’s focus on strong free cash flow generation and financial discipline. The company is also targeting net leverage of less than 2.5x.
This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.
Recommended Articles
Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.